GLIBENCLAMIDE 5mg. IP + METFORMIN 500mg. IP

A medicine that helps to control high blood glucose levels in individuals with type 2 diabetes. Helps lower both fasting and postprandial blood glucose spikes. Stimulates pancreatic beta cells to release more insulin and reduces glucose production in the liver. Reduces long-term risk of cardiovascular events associated with uncontrolled diabetes. Significantly greater reductions in HbA1C and fasting plasma glucose than metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy. (A Garber, 2006) More effective and well-tolerated than monotherapy in patients with uncontrolled hyperglycemia, regardless of age, weight, or disease severity. (A Garber M. M., 2003) An effective and safe approach for advancing oral anti-diabetic therapy. (L Blonde, 2004) More effective than these drugs alone in improving glycemic control in type 2 diabetes. (Flavia Tosi, 2003) Lowers the risk of long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular issues.